Download Haemochromatosis PCR Testing

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Vectors in gene therapy wikipedia , lookup

Mutagen wikipedia , lookup

Tay–Sachs disease wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup

BRCA mutation wikipedia , lookup

Genetic engineering wikipedia , lookup

Genome evolution wikipedia , lookup

RNA-Seq wikipedia , lookup

Gene desert wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Public health genomics wikipedia , lookup

Copy-number variation wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Cell-free fetal DNA wikipedia , lookup

Gene nomenclature wikipedia , lookup

Population genetics wikipedia , lookup

Gene expression programming wikipedia , lookup

Genome (book) wikipedia , lookup

Oncogenomics wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Gene therapy wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Epistasis wikipedia , lookup

Saethre–Chotzen syndrome wikipedia , lookup

Designer baby wikipedia , lookup

Neuronal ceroid lipofuscinosis wikipedia , lookup

Mutation wikipedia , lookup

Frameshift mutation wikipedia , lookup

Microevolution wikipedia , lookup

Point mutation wikipedia , lookup

Transcript
CS7.020/Edition: 4
Haemochromatosis PCR Testing
Haemochromatosis is an autosomal recessive disorder of iron
metabolism.
Most cases of haemochromatosis are caused by the C282Y mutation.
Approximately 1 in 200 persons of Northern European descent carry 2
copies of this gene and are at risk of developing the complications
associated with this condition.
Approximately 1 in 8 persons of Northern European descent carry a
single copy of the gene. They are unlikely to have any manifestations of
haemochromatosis, but may pass the gene copy to their children.
Only a proportion of persons who are homozygous (carry 2 copies of the
gene) for C282Y develop clinical disease. For those who do, if identified
early enough, there is excellent treatment, simply by regular removal of
blood which is the main site of iron storage in the body.
There are 2 other mutations that have been identified in the
haemochromatosis gene, know as the H63D and S65C mutations
respectively. They appear to be less important than the C282Y mutation
in causing clinical haemochromatosis, but some persons who carry 2
copies of the H63D mutation have been reported to develop clinical signs
of haemochromatosis.
ACT Pathology performs genetic testing for haemochromatosis. The
C282Y and H63D mutations are tested for on a weekly basis, using a
technique called PCR. The S65C mutation has no known association
with hereditary haemochromatosis and is not reported.
Required specimen is 4-10mL of blood collected into an EDTA tube.
For further information please contact:
Dr Peter Hickman
Director of Chemical Pathology
6244 2840
Senior Scientist
Molecular Pathology
62443485
Authorised by Director of Chemical Pathology
Last Updated: 28/11/2011